Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
Infection Control and Hospital Epidemiology
|
March 13, 2023
Quantification of time delay between screening and subsequent initiation of contact isolation for carriers of extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales: A post hoc subgroup analysis of the R-GNOSIS WP5 Trial
Friederike Maechler, Frank Schwab, Sonja Hansen, et al.
The Journal of Antimicrobial Chemotherapy
|
December 13, 2006
CTX-M: changing the face of ESBLs in Europe
David M Livermore, Rafael Canton, Marek Gniadkowski, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 14, 2023
Antimicrobial resistance level and conjugation permissiveness shape plasmid distribution in clinical enterobacteria
Aida Alonso-Del Valle, Laura Toribio-Celestino, Anna Quirant, et al.
Biorxiv : the Preprint Server for Biology
|
June 21, 2024
Plasmid-encoded insertion sequences promote rapid adaptation in clinical enterobacteria
Jorge Sastre-Dominguez, Javier DelaFuente, Laura Toribio-Celestino, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
September 30, 2018
Defining antimicrobial resistance in cystic fibrosis
Timothy J Kidd, Rafael Canton, Miquel Ekkelenkamp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 7, 2019
Reconciling Antimicrobial Susceptibility Testing and Clinical Response in Antimicrobial Treatment of Chronic Cystic Fibrosis Lung Infections
Valerie J Waters, Timothy J Kidd, Rafael Canton, et al.
BMJ Open
|
March 4, 2019
Local prevalence of extended-spectrum beta-lactamase (ESBL) producing <i>Enterobacteriaceae</i> intestinal carriers at admission and co-expression of ESBL and OXA-48 carbapenemase in <i>Klebsiella pneumoniae</i>: a prevalence survey in a Spanish University Hospital
Cristina Díaz-Agero Pérez, Nieves López-Fresneña, Angela L Rincon Carlavilla, et al.
Antimicrobial Agents and Chemotherapy
|
August 16, 2021
Elevated MICs of Susceptible Antipseudomonal Cephalosporins in Non-Carbapenemase-Producing, Carbapenem-Resistant Pseudomonas aeruginosa: Implications for Dose Optimization
Christian M Gill, Elif Aktaş, Wadha Alfouzan, et al.
The Lancet. Infectious Diseases
|
February 23, 2020
Contact isolation versus standard precautions to decrease acquisition of extended-spectrum β-lactamase-producing Enterobacterales in non-critical care wards: a cluster-randomised crossover trial
Friederike Maechler, Frank Schwab, Sonja Hansen, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
July 22, 2021
The ERACE-PA Global Surveillance Program: Ceftolozane/tazobactam and Ceftazidime/avibactam in vitro Activity against a Global Collection of Carbapenem-resistant Pseudomonas aeruginosa
Christian M Gill, Elif Aktaþ, Wadha Alfouzan, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
Infection Control and Hospital Epidemiology
|
March 13, 2023
Quantification of time delay between screening and subsequent initiation of contact isolation for carriers of extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales: A post hoc subgroup analysis of the R-GNOSIS WP5 Trial
Friederike Maechler, Frank Schwab, Sonja Hansen, et al.
The Journal of Antimicrobial Chemotherapy
|
December 13, 2006
CTX-M: changing the face of ESBLs in Europe
David M Livermore, Rafael Canton, Marek Gniadkowski, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 14, 2023
Antimicrobial resistance level and conjugation permissiveness shape plasmid distribution in clinical enterobacteria
Aida Alonso-Del Valle, Laura Toribio-Celestino, Anna Quirant, et al.
Biorxiv : the Preprint Server for Biology
|
June 21, 2024
Plasmid-encoded insertion sequences promote rapid adaptation in clinical enterobacteria
Jorge Sastre-Dominguez, Javier DelaFuente, Laura Toribio-Celestino, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
September 30, 2018
Defining antimicrobial resistance in cystic fibrosis
Timothy J Kidd, Rafael Canton, Miquel Ekkelenkamp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 7, 2019
Reconciling Antimicrobial Susceptibility Testing and Clinical Response in Antimicrobial Treatment of Chronic Cystic Fibrosis Lung Infections
Valerie J Waters, Timothy J Kidd, Rafael Canton, et al.
BMJ Open
|
March 4, 2019
Local prevalence of extended-spectrum beta-lactamase (ESBL) producing <i>Enterobacteriaceae</i> intestinal carriers at admission and co-expression of ESBL and OXA-48 carbapenemase in <i>Klebsiella pneumoniae</i>: a prevalence survey in a Spanish University Hospital
Cristina Díaz-Agero Pérez, Nieves López-Fresneña, Angela L Rincon Carlavilla, et al.
Antimicrobial Agents and Chemotherapy
|
August 16, 2021
Elevated MICs of Susceptible Antipseudomonal Cephalosporins in Non-Carbapenemase-Producing, Carbapenem-Resistant Pseudomonas aeruginosa: Implications for Dose Optimization
Christian M Gill, Elif Aktaş, Wadha Alfouzan, et al.
The Lancet. Infectious Diseases
|
February 23, 2020
Contact isolation versus standard precautions to decrease acquisition of extended-spectrum β-lactamase-producing Enterobacterales in non-critical care wards: a cluster-randomised crossover trial
Friederike Maechler, Frank Schwab, Sonja Hansen, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
July 22, 2021
The ERACE-PA Global Surveillance Program: Ceftolozane/tazobactam and Ceftazidime/avibactam in vitro Activity against a Global Collection of Carbapenem-resistant Pseudomonas aeruginosa
Christian M Gill, Elif Aktaþ, Wadha Alfouzan, et al.
Page
of 4